List of largest biotechnology companies

From Wikipedia, the free encyclopedia
  (Redirected from List of biotechnology companies)
Jump to: navigation, search

A biotechnology company is a company whose products or services primarily use biotechnology methods for their production, design or delivery. The United Nations Convention on Biological Diversity defines 'biotechnology' as: "Any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use."[1] In other words, biotechology can be defined as the mere application of technical advances in life science to develop commercial products. Today, no comprehensive global database of biotech companies is available online, despite the fact that a free and open access project was launched in late 2014.[2]

Independent biotechnology companies[edit]

  • The following is a list of the top 25 independent biotechnology companies listed on a stock exchange ranked by Market Capitalization as of June 2015 (Q3 2015).
  • Note that it does not include biotechnology companies that are now owned by, or part of, larger pharmaceutical groups.
Rank Change Company Country Highest Market Cap ever (historical)(USD billions) Market Cap in Q2 2016 (USD billions)[3][4] Market Cap in 2015 (USD billions)[5] Market Cap in 2014 (USD billions)[6] Market Cap in 2013 (USD billions)
1 Steady Johnson & Johnson  United States 338.8 (July 2016) 333.7 284.2 277.8 258.3
2 Steady Roche   Switzerland 263.6 (February 2014) 224.6 234.7 258.5 240.3
3 Increase Pfizer  United States 310.5 (July 2000) 213.5 199.3 205.4 196.0
4 Decrease Novartis   Switzerland 275.2 (July 2015) 196.5 206.1 229.8 195.0
5 Increase Merck & Co.  United States 178.9 (January 2015) 159.5 147.6 166.9 146.5
6 Increase Novo Nordisk  Denmark 153.8 (June 2015) 139.8 153.9 125.4 19.6
7 Increase Bristol-Myers Squibb  United States 115.3 (May 2015) 122.8 114.8 97.6 87.2
8 Steady Amgen  United States 130.6 (December 2014) 114.3 122.5 93.1 78.7
9 Decrease Gilead Sciences  United States 179.6 (June 2013) 111.1 145.8 109.0 78.4
10 Decrease Sanofi  France 151.3 (September 2014) 109.3 111.8 138.1 142.0
11 Steady GlaxoSmithKline  United Kingdom 174.9 (May 2006) 105.5 97.6 128.9 129.6
12 Decrease AbbVie  United States 112.2 June 2015 100.1 96.8 104.1 83.8
13 Steady Allergan  Ireland 133.5 July 2015 91.4 123.3 68.5 29.3
14 Steady Eli Lilly & Co  United States 122.6 August 2000 86.9 93.4 76.6 57.0
15 Decrease Bayer  Germany 129 March 2015 83.2 103.2 113.2 117.4
16 Decrease Celgene  United States 102.9 March 2015 76.4 94.1 89.5 69.2
17 Decrease AstraZeneca  United Kingdom 102.9 October 2006 76.4 85.8 88.9 74.6
18 Decrease Abbott Laboratories  United States 74.8 July 2015 57.8 67.0 67.9 59.3
19 Decrease Biogen  United States 111.7 March 2015 53.0 68.3 79.7 66.1
20 Decrease Teva Pharmaceutical  Israel 58.9 April 2010 45.9 55.9 49.0 37.8
21 Decrease Stryker Corporation  United States 40.2 March 2016 44.8 34.7 35.7 28.4
22 Decrease Regeneron Pharmaceuticals Inc  United States 56.5 December 2015 36.7 56.5 42.0 27.4
23 Decrease Shire Pharmaceuticals  Ireland 52.4 October 2014 36.3 41.0 42.4 28.1
24 Decrease Alexion Pharmaceuticals  United States 43.1 June 2015 26.1 43.0 36.8 26.2
25 Decrease Baxter International  United States 23.0 August 2015 25.0 20.9 21.6 20.5

Milestones

  • Q1 2016
    • Valeant exits the top-25 list with a decrease in market cap of $25 billion.
    • Allergan, plc exits the list due to its merger with Pfizer.
    • Stryker & Baxalta enter the top-25

  • Q2 2016
    • Baxalta has been removed from the list after being acquired by Shire.
    • Allergan, plc re-enters the list due to its merger with Pfizer being called-off.
    • As a result of Allergans re-inclusion, Mylan drops out of the top-25

Graphical representation[edit]

Graphical representation of the top-25 Biotechnology companies sorted by market capitalisation for Q2 of 2016

References[edit]

  1. ^ "The Convention on Biological Diversity (Article 2. Use of Terms)." United Nations. 1992. Retrieved on February 6, 2008.
  2. ^ Carlo Alberto Oppici, Filippo Giancarlo Martinelli. "BioDirecta". Retrieved 22 March 2015. 
  3. ^ "Healthcare – Google Finance". 
  4. ^ "Healthcare – Google Finance". 
  5. ^ "The World’s Biggest Public Companies". Forbes. 
  6. ^ "• Top biotech and pharmaceutical companies market value 2015 - Statistic". Statista. 

External links[edit]